Systemic mastocytosis in adults: 2021 Update on diagnosis, risk stratification and management

Key Findings

• ●Comprehensive clinical update covering WHO classification, molecular risk stratification
• ●Identification of ASXL1/RUNX1/SRSF2/NRAS as poor-risk mutations
• ●Treatment algorithm for ISM through MCL

Referenced in (1 disease)